Acumen Pharmaceuticals, Inc. (ABOS)
0.2432
+0.02
(+8.81%)
USD |
NASDAQ |
Nov 09, 11:58
Acumen Pharmaceuticals Total Liabilities (Quarterly) : 50.96M for Sept. 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 50.96M |
| June 30, 2026 | 58.74M |
| March 31, 2026 | 46.15M |
| December 31, 2025 | 52.57M |
| September 30, 2025 | 49.05M |
| June 30, 2025 | 54.82M |
| March 31, 2025 | 48.96M |
| December 31, 2024 | 57.18M |
| September 30, 2024 | 49.77M |
| June 30, 2024 | 44.97M |
| March 31, 2024 | 38.93M |
| December 31, 2023 | 43.15M |
| Date | Value |
|---|---|
| September 30, 2023 | 6.098M |
| June 30, 2023 | 8.531M |
| March 31, 2023 | 8.779M |
| December 31, 2022 | 7.812M |
| September 30, 2022 | 6.613M |
| June 30, 2022 | 5.159M |
| March 31, 2022 | 3.998M |
| December 31, 2021 | 5.147M |
| September 30, 2021 | 1.489M |
| June 30, 2021 | 4.518M |
| March 31, 2021 | 31.18M |
| December 31, 2020 | 6.367M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 406.66M |
| Alnylam Pharmaceuticals, Inc. | 4.391B |
| Anika Therapeutics, Inc. | 52.02M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.94M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 85.56M |
| Shareholders Equity (Quarterly) | 34.61M |
| Debt to Equity Ratio | 0.7602 |
| Current Ratio | 1.888 |
| Net Debt Paydown Yield | 0.47% |